Now, for the first time, scientists from Harvard Medical School have managed to «listen in» on the crosstalk between individual microbes and the entire cast of
immune cells and genes expressed in the gut.
Not exact matches
Cancer - focused CRISPR technology involves taking a set of molecular shears
and the guiding molecule Cas9 in order to cut out unwanted
genes in
immune cells that may help proliferate cancers.
With major clinical successes in areas such as CAR - T,
gene therapy,
immune - oncology,
cell therapy
and gene editing, many see 2017 as the year that biotech really came of age.
They discovered that in the young, more
immune cells called monocytes were recruited to the lungs,
and that the
gene expression profiles of these
cells had more inflammatory features, causing greater inflammation
and more severe lung injury.
As might be expected of an autoimmune disease, where the
immune system turns on healthy tissue, all the
genes play a role in controlling the growth
and multiplication of
cells in the
immune system.
«As you look for methods to discern complex
immune responses in human
cells, more
and more people look at what
genes are turned on with infections or vaccination procedures.»
There is evidence to suggest the
gene originally controlled stem
cells or
immune response,
and was only later co-opted to defend animals against rogue
cells when they became large
and long - lived.
«We hypothesized that individual mutations in viral
genes could be expected to have a range of effects on the virus's ability to replicate, to infect new
cells and escape the
immune system,» Carlson says.
The so - called STEP trial, sponsored by pharmaceutical giant Merck & Co.
and the federally funded HIV Vaccine Trials Network (HVTN), was the first to test the idea of stimulating the
immune system's killer T
cells to hunt for the virus more aggressively, in this case using a weakened form of the cold virus to carry three
genes from HIV.
One key
gene encodes the making of a receptor called TREM2, a docking site for molecules on the surface of microglia
and other innate
immune cells.
Lu's team will extract
immune cells called T
cells from the blood of the enrolled patients,
and then use CRISPR — Cas9 technology — which pairs a molecular guide able to identify specific genetic sequences on a chromosome with an enzyme that can snip the chromosome at that spot — to knock out a
gene in the
cells.
Antibodies
and T
cells against the protein could cause the
immune system to attack
cells carrying it, making
gene therapy ineffective.
Then immunotherapy firm Juno Therapeutics shook hands with
gene - editing start - up Editas to create anticancer
immune cell therapies; Vertex Pharmaceuticals
and Crispr Therapeutics, another start - up, inked an agreement that could be valued at $ 2.6 billion; while Regeneron Pharmaceuticals formed a patent licence agreement with ERS Genomics, which holds the rights to the foundational Crispr intellectual property from Emmanuelle Charpentier, one of the Crispr pioneers.
By studying infected
cells grown in a laboratory, the team found that a large number of CMV's
genes help it hide from the
immune system by allowing it to destroy many of the proteins produced by the body during virus infection
and preventing them from activating
immune cells to destroy the virus.
By contrast, the HMS team homed in on one microbe at a time
and its effects on nearly all
immune cells and intestinal
genes, an approach that offers a more precise understanding of the interplay between individual gut microbes
and their hosts.
In another landmark success, scientists in Italy
and the United States cured «bubble» babies who have a malfunctioning
gene for the enzyme adenosine deaminase, which causes a buildup of toxic products that destroy
immune cells.
So far, scientists have been able to listen to bits
and pieces of the conversation between bacteria
and individual
immune cells or a handful of
genes.
The invasion of epithelial
cells and immune cells are controlled by two separate
gene clusters called Salmonella Pathogenicity Islands 1
and 2 (SPI1, SPI2) respectively.
Epigenetic therapies are thought to work in two ways to fix these errors in cancer
cells — by correcting the «position» of the
gene switches
and by making the
cell appear as though it's infected by a virus, triggering the
immune system.
2011: Another success makes headlines: David Porter
and Carl June report that
immune cells modified with
gene therapy had cured two terminal leukemia patients of their cancer.
genes, the team has shown that B. theta helps guide the normal development
and functioning of the intestines — including the growth of blood vessels, the proper turnover of epithelial
cells,
and the marshaling of components of the
immune system needed to keep less well behaved bacteria at bay.
This program, resulting in shorter 3 ′ UTRs, is a characteristic of
gene expression during
immune cell activation
and correlates with proliferation across diverse
cell types
and tissues.
However, ChABC
gene therapy decreased the presence of these
cells and increased the presence of other
immune cells called M2 macrophages that help to reduce inflammation
and enhance tissue repair.
In a related paper published online today in Nature Biotechnology, Konrad Hochedlinger of the Harvard Stem
Cell Institute in Cambridge
and his colleagues compared the
gene expression patterns in mouse iPS
cells derived from white blood
cells, muscle precursor
cells,
immune system
cells called B
cells,
and fibroblasts taken from tail tips.
«We also found that reduced cohesin led to changes in the expression of
genes involved in nerve
cell development
and the response to an
immune signaling protein,» corresponding author Toshihide Yamashita says.
According to Beg, NF - κB proteins regulate key
genes involved in
immune response, inflammation,
cell death
and cell growth.
Although the correct
gene did manufacture Factor 9 in the patients for a few weeks, soon their
immune systems had wiped out the new
cells containing AAV —
and the precious
gene for Factor 9.
The technical advances emerging from
gene therapy have fueled the larger fields of
cell and immune therapy, where DNA,
immune molecules,
and viruses are all elements to be manipulated, in concert or one at a time.
The function of these
genes were involved in molecular maintenance strategies, such as DNA repair, chromosomal maintenance,
immune response
and programmed
cell death The authors argue that the «slower rate of change in these functions is consistent with increased constraint on somatic
cell maintenance as would be required in these relatively long - lived
and large - bodied mammals, illustrated by the additional large
and long - lived species with slower rates in these
genes (e.g. double - strand break repair
gene XRCC4 is also highly constrained in elephant.»
Coussens
and her U.C.S.F. colleagues Douglas Hanahan
and Zena Werb reported in 1999 that mice engineered with activated cancer
genes but without mast
cells (another type of innate
immune cell) developed premalignant tissue that did not progress to full malignancy.
The proposed clinical trial, in which researchers would use CRISPR to engineer
immune cells to fight cancer, won approval from the Recombinant DNA Advisory Committee (RAC) at the U.S. National Institutes of Health, a panel that has traditionally vetted the safety
and ethics of
gene therapy trials funded by the U.S. government
and others.
«Research into basic workings of
immune system points to way of improving therapies for cancer: Differences in wiring of «exhausted»
and effective T
cells indicate possible
gene - editing targets.»
In contrast, lymphocytes in both types of endothelial
cell grafts expressed higher levels of
genes known to be involved in dampening the
immune response
and inducing self - tolerance.
Based on studies of
gene activity
and immune cells, he found that these mammals have «domesticated» implantation's inflammatory response.
Now stem
cells are being combined with
gene and immune therapies, compounding the pace of progress.
They systematically deleted
genes for secreted effector proteins — molecules that the parasite injects into a host
cell to modulate the
immune system during infection —
and injected the altered parasites into mice with aggressive ovarian cancer.
Glk1 is a transcription factor, meaning it binds to specific regions of DNA
and activates
genes involved in
cell death
and other plant
immune responses.
The researchers found that the
gene expression levels in
immune cells changed in response to the macaque's new social rank within 3 months of establishing the new groups,
and the
cells got better at fighting infection.
With
gene - editing tools such as CRISPR, scientists can now eliminate
immune - provoking sugars from the surface of pig
cells, introduce human
genes that regulate blood coagulation to prevent dangerous clots,
and snip out viral sequences that some fear could infect a human host.
As part of this effort, Dr. Weinstein
and his colleagues inserted a
gene for a protein that turns green the
cells that line the endothelium of selected embryonic veins
and in the lymphatic system — the network of vessels through which
immune cells travel in the body.
After 3 months, the researchers drew blood samples from the monkeys, purified five different types of
immune cells,
and measured
gene expression across their entire genomes.
The research team used blood samples taken daily throughout the patient's hospitalization
and recovery to measure the rise
and decline of virus replication inside white blood
cells and serum
and to track the timing, intensity
and duration of expression of numerous
immune system
genes.
In a study led by Eli
and Edythe Broad Center of Regenerative Medicine
and Stem
Cell Research member Dr. Julian Martinez - Agosto, UCLA scientists have shown that two
genes not previously known to be involved with the
immune system play a crucial role in how progenitor stem
cells are activated to fight infection.
This result reflected earlier findings that ILC
and T
cell subclasses produce similar sets of cytokines, but also revealed differences in how the two
cell types control the activities of these key
immune response
genes.
When the team looked at what
gene signatures the RORγt - dependent ILCs expressed, they found high expression of major histocompatibility complex class II (MHCII) protein, which some
cells use to display foreign proteins to the
immune system
and directly interact with T
cells.
The Münster immunologists found a test - tube alternative for this, too: they used the molecular biological method of genome editing to systematically «cut out» the
gene segment relevant for VLA4
and produce the appropriate «deficient»
immune cells.
The investigators also measured
gene expression of postvaccinated cervical
cells in three of the patients
and found increased expression of several
genes (CXCR3, Tbet
and IFNβ) associated with activation of the
immune system.
The infection rapidly turned on a wide range of
genes involved in
immune system activation
and cell death, they conclude, bolstering the hypothesis that the greatest harm may not have been done by the virus itself, but by an over-reactive
immune system.
It is surprising to find that a single
gene (ESRP), through its ancestral biological role (
cell adherence
and motility) has been used throughout the animal scale for very different purposes: from the
immune system of an echinoderm to the lips, lungs or inner ears of humans,» states professor Jordi Garcia - Fernàndez, of the University of Barcelona's Department of Genetics, Microbiology
and Statistics
and the IBUB.
The researchers removed
immune cells from the recipient's blood
and then disabled a
gene in them using CRISPR — Cas9, which combines a DNA - cutting enzyme with a molecular guide that can be programmed to tell the enzyme precisely where to cut.